Jeff Yass’s Revelation Biosciences Warrant REVBW Stock Holding History

Jeff Yass’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262	Buy	+42,266	New	+$440	﹤0.01%	13270
2025 Q3	–	Sell	-33,468	Closed	-$402	–	13661
2025 Q2	$402	Buy	+33,468	New	+$405	﹤0.01%	12528
2024 Q3	–	Sell	-14,575	Closed	-$292	–	12862
2024 Q2	$292	Buy	+14,575	New	+$238	﹤0.01%	11893
2022 Q3	–	Sell	-14,418	Closed	-$1K	–	13965
2022 Q2	$1K	Buy	+14,418	New	+$1.21K	﹤0.01%	12726
2021 Q4	–	Sell	-19,236	Closed	-$12K	–	13771
2021 Q3	$12K	Buy	19,236 +7,972	+71%	+$4.83K	﹤0.01%	12595
2021 Q2	$7K	Buy	+11,264	New	+$6.71K	﹤0.01%	12452

Other funds holding REVBW

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

SIA

Soltis Investment Advisors St. George, Utah $1.8B AUM 27.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jeff Yass's REVBW Position: Q2 2026 in Review

Jeff Yass opened a new position in Revelation Biosciences Warrant (REVBW) in Q2 2026: 42,266 shares worth $262. The stake represents ﹤0.01% of the portfolio and ranks #13270 among its holdings. This is a return to the name: Jeff Yass previously reported a position in REVBW as recently as Q2 2025.

Jeff Yass first reported a position in REVBW in Q2 2021 and has held it in 6 quarters since. The position peaked at $12K in Q3 2021. 13 funds tracked by Wall St. Rank hold REVBW as of Q2 2026.

Jeff Yass held 42,266 shares of Revelation Biosciences Warrant worth $262 as of Q2 2026.
Revelation Biosciences Warrant was a new Jeff Yass position in Q2 2026.
Revelation Biosciences Warrant made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13270 holding.
Jeff Yass first reported a position in Revelation Biosciences Warrant in Q2 2021 and has held it in 6 quarters since.
Jeff Yass's Revelation Biosciences Warrant position peaked at $12K in Q3 2021.
13 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.